Patents Act, 1970
24A. Application for grant of exclusive rights
(1) Notwithstanding anything contained in sub-section (1) of section
12, the Controller shall not, under that sub-section, refer an application in
respect of a claim for a patent covered under sub-section (2) of section 5 to
an examiner for making a report till the 31st day of December, 2004 and shall,
where an application for grant of exclusive right to sell or distribute the
article or substance in India has been made in the prescribed form and manner
and on payment of prescribed fee, refer the application for patent, to an
examiner for making a report to him as to whether the invention is not an
invention within the meaning of this Act in terms of section 3 or the invention
is an invention for which no patent can be granted in terms of section 4.
(2) Where the Controller, on receipt of a report under
sub-section (1) and after such other investigation as he may deem necessary, is
satisfied that the invention is not an invention within the meaning of this Act
in terms of section 3 or the invention is an invention for which no patent can
be granted in terms of section 4, he shall reject the application for exclusive
right to sell or distribute the article or substance.
(3) In a case where an application for exclusive right to sell
or distribute an article or a substance is not rejected by the Controller on
receipt of a report under sub-section (1) and after such other investigation,
if any, made by him, he may proceed to grant exclusive right to sell or
distribute the article or substance in the manner provided in section 24B.
Explanation: It is hereby clarified that for the purposes
of this section, the exclusive right to sell or distribute any article or
substance under this section shall not include any, article or substance based
on the system of Indian medicine as defined in clause (e) of sub-section (1) of
section 2 of the Indian Medicine Central Council Act, 1970 (48 of 1970) and
where such article or substance is already in the public domain.